Brown Advisory Inc. Decreases Stock Holdings in HealthEquity, Inc. $HQY

Brown Advisory Inc. trimmed its holdings in HealthEquity, Inc. (NASDAQ:HQY) by 5.6% during the fourth quarter, HoldingsChannel reports. The firm owned 1,515,259 shares of the company’s stock after selling 90,014 shares during the period. Brown Advisory Inc.’s holdings in HealthEquity were worth $138,813,000 at the end of the most recent reporting period.

Other institutional investors have also bought and sold shares of the company. Capricorn Fund Managers Ltd acquired a new stake in shares of HealthEquity during the 4th quarter worth approximately $6,926,000. King Luther Capital Management Corp increased its holdings in shares of HealthEquity by 60.6% during the 3rd quarter. King Luther Capital Management Corp now owns 80,584 shares of the company’s stock worth $7,637,000 after buying an additional 30,394 shares during the last quarter. JPMorgan Chase & Co. increased its holdings in shares of HealthEquity by 11.5% during the 3rd quarter. JPMorgan Chase & Co. now owns 1,205,077 shares of the company’s stock worth $114,205,000 after buying an additional 124,283 shares during the last quarter. Vanguard Group Inc. increased its holdings in shares of HealthEquity by 2.9% during the 3rd quarter. Vanguard Group Inc. now owns 8,746,255 shares of the company’s stock worth $828,883,000 after buying an additional 243,549 shares during the last quarter. Finally, Congress Asset Management Co. increased its holdings in shares of HealthEquity by 36.3% during the 4th quarter. Congress Asset Management Co. now owns 101,816 shares of the company’s stock worth $9,327,000 after buying an additional 27,102 shares during the last quarter. 99.55% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at HealthEquity

In related news, EVP Delano Ladd sold 7,500 shares of HealthEquity stock in a transaction that occurred on Thursday, May 28th. The shares were sold at an average price of $90.00, for a total value of $675,000.00. Following the completion of the sale, the executive vice president owned 91,141 shares in the company, valued at approximately $8,202,690. This trade represents a 7.60% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Michael Henry Fiore sold 3,142 shares of HealthEquity stock in a transaction that occurred on Friday, May 29th. The shares were sold at an average price of $95.00, for a total transaction of $298,490.00. Following the completion of the sale, the executive vice president owned 59,113 shares of the company’s stock, valued at $5,615,735. This trade represents a 5.05% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 13,081 shares of company stock worth $1,193,000. Insiders own 1.60% of the company’s stock.

HealthEquity Stock Down 0.7%

HealthEquity stock opened at $88.34 on Friday. HealthEquity, Inc. has a fifty-two week low of $72.76 and a fifty-two week high of $106.60. The company has a debt-to-equity ratio of 0.46, a quick ratio of 3.44 and a current ratio of 3.44. The firm has a 50 day moving average price of $84.64 and a 200 day moving average price of $85.87. The company has a market capitalization of $7.39 billion, a PE ratio of 33.09, a price-to-earnings-growth ratio of 1.49 and a beta of 0.21.

HealthEquity (NASDAQ:HQY) last posted its earnings results on Thursday, May 28th. The company reported $1.24 earnings per share for the quarter, beating the consensus estimate of $1.11 by $0.13. HealthEquity had a net margin of 17.25% and a return on equity of 14.75%. The firm had revenue of $354.64 million during the quarter, compared to the consensus estimate of $352.02 million. The company’s revenue for the quarter was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. Research analysts expect that HealthEquity, Inc. will post 3.92 earnings per share for the current year.

Analysts Set New Price Targets

HQY has been the subject of a number of recent analyst reports. Wells Fargo & Company set a $111.00 price target on shares of HealthEquity in a report on Monday, June 1st. Raymond James Financial set a $100.00 price target on shares of HealthEquity in a report on Tuesday, February 17th. KeyCorp restated an “overweight” rating on shares of HealthEquity in a report on Tuesday, May 26th. JPMorgan Chase & Co. cut their price target on shares of HealthEquity from $129.00 to $123.00 and set an “overweight” rating for the company in a report on Wednesday, March 18th. Finally, Deutsche Bank Aktiengesellschaft raised their price target on shares of HealthEquity from $120.00 to $128.00 and gave the stock a “buy” rating in a report on Thursday, March 19th. One investment analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating, one has given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, HealthEquity presently has an average rating of “Moderate Buy” and an average target price of $110.57.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.